Pukrittayakamee S, Supanaranond W, Looareesuwan S, Vanijanonta S, White N J
Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Thailand.
Trans R Soc Trop Med Hyg. 1994 May-Jun;88(3):324-7. doi: 10.1016/0035-9203(94)90102-3.
Between 1981 and 1992, 196 Thai adults with severe falciparum malaria were treated with a quinine loading dose regimen. Nineteen patients died (10%) and 6 developed late hypoglycaemia. There was no serious cardiovascular or nervous system toxicity. Although there was no evidence of high grade resistance, and no change in the mortality rate, in recent years an increasing proportion of patients had a delayed clinical and parasitological response to treatment. Since 1988, 78% (29/37) of patients with cerebral malaria were unconscious for > 72 h compared with 41% (11/27) between 1981 and 1987 (P = 0.002). In the past 2 years parasite clearance times have exceeded 96 h in 33% (26/78) of patients compared with 14% (15/102) previously (P = 0.006). Quinine remains an effective treatment for severe multi-drug resistant falciparum malaria in this area, but there is now evidence of a decline in the immediate therapeutic response, and its efficacy will need close monitoring as resistance increases further.
1981年至1992年间,196名患有严重恶性疟原虫疟疾的泰国成年人接受了奎宁负荷剂量治疗方案。19名患者死亡(10%),6名出现迟发性低血糖。未出现严重的心血管或神经系统毒性。虽然没有证据表明存在高度耐药性,死亡率也没有变化,但近年来,越来越多的患者对治疗的临床和寄生虫学反应出现延迟。自1988年以来,78%(29/37)的脑型疟患者昏迷超过72小时,而1981年至1987年间这一比例为41%(11/27)(P = 0.002)。在过去两年中,33%(26/78)的患者寄生虫清除时间超过96小时,而之前这一比例为14%(15/102)(P = 0.006)。奎宁仍然是该地区严重多药耐药恶性疟的有效治疗药物,但现在有证据表明即时治疗反应有所下降,随着耐药性进一步增加,其疗效需要密切监测。